<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/atom10full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><feed xmlns="http://www.w3.org/2005/Atom">
 
 <title>Research Blogging - Health - Portuguese</title>
 <subtitle />
 
 <link href="http://www.researchblogging.org" />
 <updated>2012-05-26T04:00:01Z</updated>
 <author>
   <name>Research Blogging</name>
   <email>noreply@researchblogging.org</email>
 </author>
 <id>http://www.researchblogging.org/feeds/health/portuguese.xml</id>
 
  <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/atom+xml" href="http://feeds.feedburner.com/ResearchBloggingHealthPortuguese" /><feedburner:info xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" uri="researchblogginghealthportuguese" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><entry>
   <title type="html"><![CDATA[Botox no tratamento profil&aacute;tico da enxaqueca]]></title>
   <link href="http://www.naodouatestado.com.br/2012/05/23/botox-no-tratamento-profilatico-da-enxaqueca/" />
   <id>http://www.naodouatestado.com.br/2012/05/23/botox-no-tratamento-profilatico-da-enxaqueca/</id>
      <category term="Health" />
      <author>
	  <name><![CDATA[Rafael Pivovar, Não dou atestado]]></name>
	</author>
   <updated>2012-05-23T17:37:47Z</updated>
   <!-- 2003-12-13T18:30:02Z -->
   <summary type="html"><![CDATA[Os usos est&eacute;ticos da toxina botul&iacute;nica, ou simplesmente Botox, j&aacute; s&atilde;o bem conhecidos e amplamente divulgados. Acredita-se que a tens&atilde;o cont&iacute;nua dos m&uacute;sculos posteriores do pesco&ccedil;o poderia funcionar como gatilho para desencadear as crises de enxaqueca, o Botox, assim, ao relaxar estes m&uacute;sculos estaria ajudando a prevenir a recorr&ecirc;ncia e intensidade dos epis&oacute;dios dolorosos....<br><br><div style="background-color: #eee; padding: 6px; font-size: 11px;">

	    <p>
    Jackson, J., Kuriyama, A., & Hayashino, Y. (2012) <a href="http://dx.doi.org/10.1001/jama.2012.505" class="blue">Botulinum Toxin A for Prophylactic Treatment of Migraine and Tension Headaches in Adults: A Meta-analysis</a>. JAMA: The Journal of the American Medical Association, 307(16), 1736-1745. DOI:&nbsp;<a href="http://dx.doi.org/10.1001/jama.2012.505" class="blue">10.1001/jama.2012.505</a>&nbsp;&nbsp;<script src="http://pubget.com/widgetizer/link_js?doi=10.1001/jama.2012.505"></script><noscript><a href="http://pubget.com/doi/10.1001/jama.2012.505">Botulinum Toxin A for Prophylactic Treatment of Migraine and Tension Headaches in Adults: A Meta-analysis</a></noscript>    </p>

	    <p>
    Binder WJ, Brin MF, Blitzer A, Schoenrock LD, & Pogoda JM. (2000) <a href="http://www.ncbi.nlm.nih.gov/pubmed/11112955" class="blue">Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study.</a> Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 123(6), 669-76. PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/11112955" class="blue">11112955</a>&nbsp;&nbsp;<script src="http://pubget.com/widgetizer/link_js?pmid=11112955"></script> <noscript><a href="http://pubget.com/paper/11112955">Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study.</a></noscript>    </p>
</div><br>]]></summary>
 </entry>
  <entry>
   <title type="html"><![CDATA[Suco de Cranberry na preven&ccedil;&atilde;o de infec&ccedil;&otilde;es do trato urin&aacute;rio]]></title>
   <link href="http://www.naodouatestado.com.br/2012/05/15/suco-de-cranberry-na-prevencao-de-infeccoes-do-trato-urinario/" />
   <id>http://www.naodouatestado.com.br/2012/05/15/suco-de-cranberry-na-prevencao-de-infeccoes-do-trato-urinario/</id>
      <category term="Health" />
      <author>
	  <name><![CDATA[Rafael Pivovar, Não dou atestado]]></name>
	</author>
   <updated>2012-05-15T15:12:18Z</updated>
   <!-- 2003-12-13T18:30:02Z -->
   <summary type="html"><![CDATA[As infec&ccedil;&otilde;es do trato urin&aacute;rio s&atilde;o muito comuns entre as mulheres, principalmente ap&oacute;s a menopausa. Nos &uacute;ltimos anos produtos a base de Cranberry tem sido utilizados como profilaxia das infec&ccedil;&otilde;es do trato urin&aacute;rio, por&eacute;m sua efic&aacute;cia ainda n&atilde;o pode ser comprovada pelos estudos cl&iacute;nicos realizados....<br><br><div style="background-color: #eee; padding: 6px; font-size: 11px;">

	    <p>
    Beerepoot, M., ter Riet, G., Nys, S., van der Wal, W., de Borgie, C., de Reijke, T., Prins, J., Koeijers, J., Verbon, A., Stobberingh, E.... (2011) <a href="http://dx.doi.org/10.1001/archinternmed.2011.306" class="blue">Cranberries vs Antibiotics to Prevent Urinary Tract Infections: A Randomized Double-blind Noninferiority Trial in Premenopausal Women</a>. Archives of Internal Medicine, 171(14), 1270-1278. DOI:&nbsp;<a href="http://dx.doi.org/10.1001/archinternmed.2011.306" class="blue">10.1001/archinternmed.2011.306</a>&nbsp;&nbsp;<script src="http://pubget.com/widgetizer/link_js?doi=10.1001/archinternmed.2011.306"></script><noscript><a href="http://pubget.com/doi/10.1001/archinternmed.2011.306">Cranberries vs Antibiotics to Prevent Urinary Tract Infections: A Randomized Double-blind Noninferiority Trial in Premenopausal Women</a></noscript>    </p>

	    <p>
    Jepson RG, & Craig JC. (2008) <a href="http://www.ncbi.nlm.nih.gov/pubmed/18253990" class="blue">Cranberries for preventing urinary tract infections.</a> Cochrane database of systematic reviews (Online). PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/18253990" class="blue">18253990</a>&nbsp;&nbsp;<script src="http://pubget.com/widgetizer/link_js?pmid=18253990"></script> <noscript><a href="http://pubget.com/paper/18253990">Cranberries for preventing urinary tract infections.</a></noscript>    </p>
</div><br>]]></summary>
 </entry>
  <entry>
   <title type="html"><![CDATA[1 em cada 6 casos de c&acirc;ncer s&atilde;o causados por infec&ccedil;&otilde;es e poderiam ser prevenidos]]></title>
   <link href="http://feedproxy.google.com/~r/meiodecultura/~3/kc9idM-36oE/" />
   <id>http://feedproxy.google.com/~r/meiodecultura/~3/kc9idM-36oE/</id>
      <category term="Health" />
      <author>
	  <name><![CDATA[Samir Elian, Meio de Cultura]]></name>
	</author>
   <updated>2012-05-09T19:00:20Z</updated>
   <!-- 2003-12-13T18:30:02Z -->
   <summary type="html"><![CDATA[Dentre dos fatores de risco para o desenvolvimento de cânceres estão as infecções por microrganismos e parasitas. Na revista “The Lancet Oncology” de hoje (09/05/12), um grupo de cientistas franceses faz uma revisão e analisa os casos de câncer que poderiam ser atribuídos a infecções. O estudo foi baseado em publicações de casos ocorridos em [...]...<br><br><div style="background-color: #eee; padding: 6px; font-size: 11px;">

	    <p>
    de Martel, C., Ferlay, J., Franceschi, S., Vignat, J., Bray, F., Forman, D., & Plummer, M. (2012) <a href="http://dx.doi.org/10.1016/S1470-2045(12)70137-7" class="blue">Global burden of cancers attributable to infections in 2008: a review and synthetic analysis</a>. The Lancet Oncology. DOI:&nbsp;<a href="http://dx.doi.org/10.1016/S1470-2045(12)70137-7" class="blue">10.1016/S1470-2045(12)70137-7</a>&nbsp;&nbsp;<script src="http://pubget.com/widgetizer/link_js?doi=10.1016/S1470-2045(12)70137-7"></script><noscript><a href="http://pubget.com/doi/10.1016/S1470-2045(12)70137-7">Global burden of cancers attributable to infections in 2008: a review and synthetic analysis</a></noscript>    </p>
</div><br>]]></summary>
 </entry>
  <entry>
   <title type="html"><![CDATA[Of model hosts and man: using Caenorhabditis elegans, Drosophila melanogaster and Galleria mellonella as model hosts for infectious disease research]]></title>
   <link href="http://limi-lip.blogspot.com.br/2012/04/of-model-hosts-and-man-using.html" />
   <id>http://limi-lip.blogspot.com.br/2012/04/of-model-hosts-and-man-using.html</id>
      <category term="Health" />
      <author>
	  <name><![CDATA[Katrine Cavalvante e Kleverton da Silva, SCIENCIA TOTUM CIRCUMIT ORBEM]]></name>
	</author>
   <updated>2012-04-17T06:00:00Z</updated>
   <!-- 2003-12-13T18:30:02Z -->
   <summary type="html"><![CDATA[Uma quest&atilde;o muito importante abordada pelos autores &eacute; a possibilidade de substitui&ccedil;&atilde;o de modelos experimentais utilizando mam&iacute;feros por animais invertebrados, devido, principalmente, &agrave;s quest&otilde;es &eacute;ticas envolvidas, baixo custo e f&aacute;cil manipula&ccedil;&atilde;o.

&middot; Os estudos realizados nesses modelos experimentais baseiam-se em testes gen&eacute;ticos, avalia&ccedil;&atilde;o da resposta imune e busca de novos f&aacute;rmacos para o tratamento de doen&ccedil;as infecciosas que afetam o homem e outros animais.

&middot; Esses modelos t&ecirc;m uma grande potencialidade a ser explorado, o que pode ser alcan&ccedil;ado com o uso de novas ferramentas biotecnol&oacute;gicas recentemente descobertas e aplica&ccedil;&otilde;es alternativas de t&eacute;cnicas j&aacute; conhecidas....<br><br><div style="background-color: #eee; padding: 6px; font-size: 11px;">

	    <p>
    Glavis-Bloom J, Muhammed M, & Mylonakis E. (2012) <a href="http://www.ncbi.nlm.nih.gov/pubmed/22127881" class="blue">Of model hosts and man: using Caenorhabditis elegans, Drosophila melanogaster and Galleria mellonella as model hosts for infectious disease research.</a> Advances in experimental medicine and biology, 11-7. PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/22127881" class="blue">22127881</a>&nbsp;&nbsp;<script src="http://pubget.com/widgetizer/link_js?pmid=22127881"></script> <noscript><a href="http://pubget.com/paper/22127881">Of model hosts and man: using Caenorhabditis elegans, Drosophila melanogaster and Galleria mellonella as model hosts for infectious disease research.</a></noscript>    </p>
</div><br>]]></summary>
 </entry>
  <entry>
   <title type="html"><![CDATA[Citometria de fluxo para avaliar infec&ccedil;&atilde;o por esporozo&iacute;tos de Plasmodium falciparum]]></title>
   <link href="http://limi-lip.blogspot.com.br/2012/04/citometria-de-fluxo-para-avaliar.html" />
   <id>http://limi-lip.blogspot.com.br/2012/04/citometria-de-fluxo-para-avaliar.html</id>
      <category term="Health" />
      <author>
	  <name><![CDATA[Gabriela B. C. Garcia, SCIENCIA TOTUM CIRCUMIT ORBEM]]></name>
	</author>
   <updated>2012-04-05T06:59:18Z</updated>
   <!-- 2003-12-13T18:30:02Z -->
   <summary type="html"><![CDATA[A malaria resulta, anualmente, em 800.000 mortes em todo o mundo (Snow et al, 2005). A infec&ccedil;&atilde;o sintom&aacute;tica pelo Plasmodium s&oacute; &eacute; detectada quando os merozo&iacute;tos infectam as hem&aacute;cias, ap&oacute;s a reprodu&ccedil;&atilde;o dos esporozo&iacute;tos nos hepat&oacute;citos (Vaughan et al, 2008). O desenvolvimento de mecanismos que interfiram na infec&ccedil;&atilde;o pr&eacute;-eritroc&iacute;tica &eacute; fundamental, visto a aus&ecirc;ncia de sintomas cl&iacute;nicos no est&aacute;gio hep&aacute;tico da doen&ccedil;a. 
Ensaios para mensurar a inibi&ccedil;&atilde;o da infec&ccedil;&atilde;o pr&eacute;-cl&iacute;nica s&atilde;o datados da d&eacute;cada de 1980 e basearam-se em microscopia. Em busca de mecanismos que possam monitorar quantitativamente as taxas de invas&atilde;o e inibi&ccedil;&atilde;o, Kaushansky et al (2012) propuseram um teste por citometria de fluxo. ...<br><br><div style="background-color: #eee; padding: 6px; font-size: 11px;">

	    <p>
    Kaushansky, A., Rezakhani, N., Mann, H., & Kappe, S. (2012) <a href="http://dx.doi.org/10.1016/j.molbiopara.2012.01.006" class="blue">Development of a quantitative flow cytometry-based assay to assess infection by Plasmodium falciparum sporozoites</a>. Molecular and Biochemical Parasitology, 183(1), 100-103. DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.molbiopara.2012.01.006" class="blue">10.1016/j.molbiopara.2012.01.006</a>&nbsp;&nbsp;<script src="http://pubget.com/widgetizer/link_js?doi=10.1016/j.molbiopara.2012.01.006"></script><noscript><a href="http://pubget.com/doi/10.1016/j.molbiopara.2012.01.006">Development of a quantitative flow cytometry-based assay to assess infection by Plasmodium falciparum sporozoites</a></noscript>    </p>
</div><br>]]></summary>
 </entry>
  <entry>
   <title type="html"><![CDATA[Hiding in Plain Sight: How HIV Evades Innate Immune Responses]]></title>
   <link href="http://limi-lip.blogspot.com.br/2012/04/hiding-in-plain-sight-how-hiv-evades.html" />
   <id>http://limi-lip.blogspot.com.br/2012/04/hiding-in-plain-sight-how-hiv-evades.html</id>
      <category term="Health" />
      <author>
	  <name><![CDATA[Ana Paula de Souza e Daniela Almeida, SCIENCIA TOTUM CIRCUMIT ORBEM]]></name>
	</author>
   <updated>2012-04-04T06:00:00Z</updated>
   <!-- 2003-12-13T18:30:02Z -->
   <summary type="html"><![CDATA[O artigo &ldquo;Hiding in Plain Sight: How HIV Evades Innate Immune Responses&rdquo;, publicado na Cell em 2011, revisa os avan&ccedil;os sobre a resposta imune inata contra infec&ccedil;&otilde;es pelo HIV-1 e outros lentiv&iacute;rus, discutindo-se aspectos da prote&ccedil;&atilde;o do hospedeiro e estrat&eacute;gias de vacina&ccedil;&atilde;o....<br><br><div style="background-color: #eee; padding: 6px; font-size: 11px;">

	    <p>
    Manel, N., & Littman, D. (2011) <a href="http://dx.doi.org/10.1016/j.cell.2011.09.010" class="blue">Hiding in Plain Sight: How HIV Evades Innate Immune Responses</a>. Cell, 147(2), 271-274. DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.cell.2011.09.010" class="blue">10.1016/j.cell.2011.09.010</a>&nbsp;&nbsp;<script src="http://pubget.com/widgetizer/link_js?doi=10.1016/j.cell.2011.09.010"></script><noscript><a href="http://pubget.com/doi/10.1016/j.cell.2011.09.010">Hiding in Plain Sight: How HIV Evades Innate Immune Responses</a></noscript>    </p>
</div><br>]]></summary>
 </entry>
  <entry>
   <title type="html"><![CDATA[Disease Tolerance as a Defense Strategy]]></title>
   <link href="http://limi-lip.blogspot.com.br/2012/04/disease-tolerance-as-defense-strategy.html" />
   <id>http://limi-lip.blogspot.com.br/2012/04/disease-tolerance-as-defense-strategy.html</id>
      <category term="Health" />
      <author>
	  <name><![CDATA[Marina Loyola e Laís Pereira, SCIENCIA TOTUM CIRCUMIT ORBEM]]></name>
	</author>
   <updated>2012-04-03T06:00:00Z</updated>
   <!-- 2003-12-13T18:30:02Z -->
   <summary type="html"><![CDATA[A auto-prote&ccedil;&atilde;o contra doen&ccedil;as infecciosas e redu&ccedil;&atilde;o de seus danos s&atilde;o relacionadas com mecanismos de anula&ccedil;&atilde;o, resist&ecirc;ncia e toler&acirc;ncia ao agente infeccioso.
Mecanismo de toler&acirc;ncia e resist&ecirc;ncia de um indiv&iacute;duo est&aacute; relacionado com sua idade, gen&eacute;tica e com a virul&ecirc;ncia do pat&oacute;geno.
O mecanismo de toler&acirc;ncia do sistema imune permite novas abordagens para tratamento de infec&ccedil;&otilde;es e outras doen&ccedil;as....<br><br><div style="background-color: #eee; padding: 6px; font-size: 11px;">

	    <p>
    Medzhitov, R., Schneider, D., & Soares, M. (2012) <a href="http://dx.doi.org/10.1126/science.1214935" class="blue">Disease Tolerance as a Defense Strategy</a>. Science, 335(6071), 936-941. DOI:&nbsp;<a href="http://dx.doi.org/10.1126/science.1214935" class="blue">10.1126/science.1214935</a>&nbsp;&nbsp;<script src="http://pubget.com/widgetizer/link_js?doi=10.1126/science.1214935"></script><noscript><a href="http://pubget.com/doi/10.1126/science.1214935">Disease Tolerance as a Defense Strategy</a></noscript>    </p>
</div><br>]]></summary>
 </entry>
  <entry>
   <title type="html"><![CDATA[Cell death and infection: A double-edged sword for host and pathogen survival]]></title>
   <link href="http://limi-lip.blogspot.com.br/2012/04/cell-death-and-infection-double-edged.html" />
   <id>http://limi-lip.blogspot.com.br/2012/04/cell-death-and-infection-double-edged.html</id>
      <category term="Health" />
      <author>
	  <name><![CDATA[Lairton Borja e Eder Fialho, SCIENCIA TOTUM CIRCUMIT ORBEM]]></name>
	</author>
   <updated>2012-04-02T12:06:00Z</updated>
   <!-- 2003-12-13T18:30:02Z -->
   <summary type="html"><![CDATA[1. Durante a infec&ccedil;&atilde;o, os agentes patog&ecirc;nicos modulam as vias de morte e sobreviv&ecirc;ncia celular dependentes de mitocondria, do fator de transcri&ccedil;&atilde;o NF-&kappa;B e do inflamassoma em c&eacute;lulas do hospedeiro.
2. Produtos bacterianos modulam as vias de sinaliza&ccedil;&atilde;o de morte e sobreviv&ecirc;ncia das c&eacute;lulas do hospedeiro
3. A infec&ccedil;&atilde;o bacteriana elucida diversos mecanismos da resposta protetora e ao estresse, incluindo morte celular, resposta proliferativa, inflamat&oacute;ria e resposta imune inata....<br><br><div style="background-color: #eee; padding: 6px; font-size: 11px;">

	    <p>
    Ashida, H., Mimuro, H., Ogawa, M., Kobayashi, T., Sanada, T., Kim, M., & Sasakawa, C. (2011) <a href="http://dx.doi.org/10.1083/jcb.201108081" class="blue">Host-pathogen interactions: Cell death and infection: A double-edged sword for host and pathogen survival</a>. The Journal of Cell Biology, 195(6), 931-942. DOI:&nbsp;<a href="http://dx.doi.org/10.1083/jcb.201108081" class="blue">10.1083/jcb.201108081</a>&nbsp;&nbsp;<script src="http://pubget.com/widgetizer/link_js?doi=10.1083/jcb.201108081"></script><noscript><a href="http://pubget.com/doi/10.1083/jcb.201108081">Host-pathogen interactions: Cell death and infection: A double-edged sword for host and pathogen survival</a></noscript>    </p>
</div><br>]]></summary>
 </entry>
  <entry>
   <title type="html"><![CDATA[Efficient capture of infected neutrophils by dendritic cells in the skin inhibits the early anti-Leishmania response]]></title>
   <link href="http://limi-lip.blogspot.com.br/2012/03/efficient-capture-of-infected.html" />
   <id>http://limi-lip.blogspot.com.br/2012/03/efficient-capture-of-infected.html</id>
      <category term="Health" />
      <author>
	  <name><![CDATA[Sarah Falcao, SCIENCIA TOTUM CIRCUMIT ORBEM]]></name>
	</author>
   <updated>2012-03-27T06:00:00Z</updated>
   <!-- 2003-12-13T18:30:02Z -->
   <summary type="html"><![CDATA[A inocula&ccedil;&atilde;o de L. major pela picada do fleb&oacute;tomo ou pela agulha, induz intensiva infiltra&ccedil;&atilde;o de neutr&oacute;filos (PMN) que fagocitam a maioria dos parasitas, mas falham na sua elimina&ccedil;&atilde;o. Al&eacute;m disso, deple&ccedil;&atilde;o de PMNs, antes da infec&ccedil;&atilde;o, leva a uma r&aacute;pida remo&ccedil;&atilde;o dos parasitas. Assim, este trabalho visou monitorar a sequ&ecirc;ncia de eventos inflamat&oacute;rios ap&oacute;s a infec&ccedil;&atilde;o com L. major na derme da orelha do camundongo, observando ainda o papel dos neutr&oacute;filos na indu&ccedil;&atilde;o da resposta imune adaptativa, via intera&ccedil;&atilde;o com DCs....<br><br><div style="background-color: #eee; padding: 6px; font-size: 11px;">

	    <p>
    Ribeiro-Gomes FL, Peters NC, Debrabant A, & Sacks DL. (2012) <a href="http://www.ncbi.nlm.nih.gov/pubmed/22359507" class="blue">Efficient capture of infected neutrophils by dendritic cells in the skin inhibits the early anti-leishmania response.</a> PLoS pathogens, 8(2). PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/22359507" class="blue">22359507</a>&nbsp;&nbsp;<script src="http://pubget.com/widgetizer/link_js?pmid=22359507"></script> <noscript><a href="http://pubget.com/paper/22359507">Efficient capture of infected neutrophils by dendritic cells in the skin inhibits the early anti-leishmania response.</a></noscript>    </p>
</div><br>]]></summary>
 </entry>
  <entry>
   <title type="html"><![CDATA[O peso da primeira vez: Esperar um pouco pode ser um bom neg&oacute;cio.]]></title>
   <link href="http://scienceblogs.com.br/cognando/2012/03/o-peso-da-primeira-vez/" />
   <id>http://scienceblogs.com.br/cognando/2012/03/o-peso-da-primeira-vez/</id>
      <category term="Health" />
      <author>
	  <name><![CDATA[Andre Luiz Souza, ***Cognando***]]></name>
	</author>
   <updated>2012-03-25T18:40:26Z</updated>
   <!-- 2003-12-13T18:30:02Z -->
   <summary type="html"><![CDATA[Ser adolescente tem suas vantagens! Uma delas é o início da vida sexual. Para um adolescente, não tem nada melhor do que fazer sexo! E é tão bom que uma das coisas que observamos atualmente é que os adolescentes começam cada vez mais cedo a ter uma vida sexual ativa. Antigamente, ser virgem com 19 [...]...<br><br><div style="background-color: #eee; padding: 6px; font-size: 11px;">

	    <p>
    K. Paige Harden. (2012) True Love Waits? A Sibling Comparison Study of Age at First Sexual Intercourse and Romantic Relationship in Young Adulthood. Psychological Science. info:/    </p>
</div><br>]]></summary>
 </entry>
  
</feed>

